XML 34 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Financial Instruments (Tables)
9 Months Ended
Oct. 01, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets
The fair values of the Company’s derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of October 1, 2017 and December 31, 2016 are summarized as follows:
Derivative Assets
 
Balance Sheet
Location
 
Fair Value at
October 1, 2017
 
Balance Sheet
Location
 
Fair Value at
December 31, 2016
 
 
 
 
(In thousands)
 
 
 
(In thousands)
Derivative assets not designated as hedging instruments
 
Prepaid expenses and other current assets
 
$
1,184

 
Prepaid expenses and other current assets
 
$
5,873

Derivative assets designated as hedging instruments
 
Prepaid expenses and other current assets
 
1,356

 
Prepaid expenses and other current assets
 
2,890

Total
 
 
 
$
2,540

 
 
 
$
8,763


Derivative Liabilities
 
Balance Sheet
Location
 
Fair Value at
October 1, 2017
 
Balance Sheet
Location
 
Fair Value at
December 31, 2016
 
 
 
 
(In thousands)
 
 
 
(In thousands)
Derivative liabilities not designated as hedging instruments
 
Other accrued liabilities
 
$
5,547

 
Other accrued liabilities
 
$
1,002

Derivative liabilities designated as hedging instruments
 
Other accrued liabilities
 
6,202

 
Other accrued liabilities
 
703

Total
 
 
 
$
11,749

 
 
 
$
1,705

Schedule of Offsetting of Derivative Assets
The following tables set forth the offsetting of derivative assets as of October 1, 2017 and December 31, 2016:
As of October 1, 2017
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
Bank of America
 
$
2,038

 
$

 
$
2,038

 
$
(2,038
)
 
$

 
$

Wells Fargo
 
502

 

 
502

 
(502
)
 

 

Total
 
$
2,540

 
$

 
$
2,540

 
$
(2,540
)
 
$

 
$


As of December 31, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
J.P. Morgan Chase
 
$
1,492

 
$

 
$
1,492

 
$
(442
)
 
$

 
$
1,050

Wells Fargo
 
7,271

 

 
7,271

 
(1,263
)
 

 
6,008

Total
 
$
8,763

 
$

 
$
8,763

 
$
(1,705
)
 
$

 
$
7,058

Schedule of Offsetting of Derivative Liabilities
The following tables set forth the offsetting of derivative liabilities as of October 1, 2017 and December 31, 2016:
As of October 1, 2017
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount

 
(In thousands)
Bank of America
 
$
11,113

 
$

 
$
11,113

 
$
(2,038
)
 
$

 
$
9,075

Wells Fargo
 
636

 

 
636

 
(502
)
 

 
134

Total
 
$
11,749

 
$

 
$
11,749

 
$
(2,540
)
 
$

 
$
9,209


As of December 31, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Condensed Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
J.P. Morgan Chase
 
$
442

 
$

 
$
442

 
$
(442
)
 
$

 
$

Wells Fargo
 
1,263

 

 
1,263

 
(1,263
)
 

 

Total
 
$
1,705

 
$

 
$
1,705

 
$
(1,705
)
 
$

 
$

Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations
The pre-tax effects of the Company’s derivative instruments on OCI and the unaudited condensed consolidated statement of operations for the three and nine months ended October 1, 2017 and October 2, 2016 are summarized as follows:

Derivatives Designated as Hedging Instruments
 
Three Months Ended October 1, 2017
 
Gains (Losses)
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(3,538
)
 
Net revenue
 
$
(4,401
)
 
Other income (expense), net
 
$
528

Foreign currency forward contracts
 

 
Cost of revenue
 
19

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
822

 
Other income (expense), net
 

Total
 
$
(3,538
)
 
 
 
$
(3,560
)
 
 
 
$
528

_________________________
(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.

Derivatives Designated as Hedging Instruments
 
Nine Months Ended October 1, 2017
 
Gains (Losses)
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(10,590
)
 
Net revenue
 
$
(3,374
)
 
Other income (expense), net
 
$
1,196

Foreign currency forward contracts
 

 
Cost of revenue
 
5

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
457

 
Other income (expense), net
 

Total
 
$
(10,590
)
 
 
 
$
(2,912
)
 
 
 
$
1,196

_________________________
(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.

Derivatives Designated as Hedging Instruments
 
Three Months Ended October 2, 2016
 
Gains (Losses)
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(417
)
 
Net revenue
 
$
(824
)
 
Other income (expense), net
 
$
116

Foreign currency forward contracts
 

 
Cost of revenue
 
4

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
163

 
Other income (expense), net
 

Total
 
$
(417
)
 
 
 
$
(657
)
 
 
 
$
116

_______________________
(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Derivatives Designated as Hedging Instruments
 
Nine Months Ended October 2, 2016
 
Gains (Losses)
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(1,116
)
 
Net revenue
 
$
(1,543
)
 
Other income (expense), net
 
$
169

Foreign currency forward contracts
 

 
Cost of revenue
 
4

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
219

 
Other income (expense), net
 

Total
 
$
(1,116
)
 
 
 
$
(1,320
)
 
 
 
$
169

_________________________
(1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Schedule Of Derivatives Not Designated As Hedging Instruments
The effects of the Company’s non-designated hedge included in other income (expense), net in the unaudited condensed consolidated statements of operations for the three and nine months ended October 1, 2017 and October 2, 2016 are as follows:

Derivatives Not Designated as Hedging Instruments
 
Location of Gains (Losses)
Recognized in Income on Derivative
 
Three Months Ended
 
Nine Months Ended
 
October 1, 2017
 
October 2, 2016
 
October 1, 2017
 
October 2, 2016
 
 
 
 
(In thousands)
Foreign currency forward contracts
 
Other income (expense), net
 
$
(1,925
)
 
$
(493
)
 
$
(6,171
)
 
$
(1,252
)